Spontaneous reporting of adverse drug reactions. II: Uses.

Abstract

Despite its inherent limitations, discussed previously Although this review concentrates on the British experience, it must be stressed that other national schemes have made equally important contributions especially those in Scandinavia, Holland, Australia and New Zealand, and North America. The schemes in West Germany, Spain and France, as a result of recent changes, are likely to become more prominent in the future.